A61K2039/5555 - CPC Classification Index

#1

20260048113

2026-02-19

ADJUVANTED IMMUNOGENIC COMPOSITION AGAINST NEISSERIA MENINGITIDIS B

#2

20250170237

2025-05-29

MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF

#3

20250059256

2025-02-20

HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF

#4

20240398915

2024-12-05

NEMATODE VACCINE

#5

20240390478

2024-11-28

VACCINATION IN ELDERLY PATIENTS

#6

20240299532

2024-09-12

SUBUNIT VACCINES WITH DINUCLEOTIDE-LOADED HYDROGEL ADJUVANT

#7

20240197857

2024-06-20

Vaccination with mRNA-coded antigens

#8

20240165200

2024-05-23

CATH2 AND DERIVATIVES FOR INHIBITING STREPTOCOCCUS SUIS

#9

20230181708

2023-06-15

IPSC-BASED VACCINE AS A PROPHYLACTIC AND THERAPEUTIC TREATMENT FOR CANCER

#10

20220073446

2022-03-10

Antigen Delivery Vectors and Constructs

#11

20220056080

2022-02-24

Muramyl peptide derivatives

#12

20210187093

2021-06-24

Vaccine compositions

#13

20210023199

2021-01-28

VACCINATION WITH mRNA-CODED ANTIGENS

#14

20210015913

2021-01-21

Immunopotentiator, foot-and-mouth disease inactivated vaccine and preparation method thereof

#15

20200407420

2020-12-31

HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF

#16

20190185542

2019-06-20

HER-1, HER-3 and IGF-1R compositions and uses thereof

#17

20190151438

2019-05-23

VACCINATION WITH mRNA-CODED ANTIGENS

#18

20180371023

2018-12-27

Muramyl peptide derivative compound, synthesis and uses thereof

#19

20180360957

2018-12-20

Muramyl peptide derivative compound, synthesis and uses thereof

#20

20170182150

2017-06-29

Vaccination with mRNA-coded antigens

#21

20170014502

2017-01-19

Vaccine compositions

#22

20160199484

2016-07-14

Fowl adenovirus vaccine

#23

20160030558

2016-02-04

ENHANCEMENT OF VACCINES

#24

20160002313

2016-01-07

HER-1, HER-3 and IGF-1R compositions and uses thereof

#25

20150141352

2015-05-21

Bone loss preventing and bone regeneration or bone formation promoting pharmaceutical composition comprising muramyl dipeptide

#26

20150112042

2015-04-23

Antigen delivery vectors and constructs

#27

20150056242

2015-02-26

Live recombinant booster vaccine against tuberculosis

#28

20140099358

2014-04-10

Vaccines with enhanced immune response and methods for their preparation

#29

20140065185

2014-03-06

Mucosal immunization

#30

20130064844

2013-03-14

NON-SPLICING VARIANTS OF GP350/220

#31

20120315293

2012-12-13

Antigen delivery vectors and constructs

#32

20120219586

2012-08-30

Adjuvanted vaccine formulations

#33

20120156282

2012-06-21

EXPANDING THE T CELL REPERTOIRE TO INCLUDE SUBDOMINANT EPITOPES BY VACCINATION WITH ANTIGENS DELIVERED AS PROTEIN FRAGMENTS OR PEPTIDE COCKTAILS

#34

20120121710

2012-05-17

Mucosal Immunization

#35

20120058136

2012-03-08

NON-SPLICING VARIANTS OF gp350/220

#36

20120034259

2012-02-09

Antigen delivery vectors and constructs

#37

20110223197

2011-09-15

Mucosal and Systemic Immunization with Alphavirus Replicon Particles

#38

20110217307

2011-09-08

Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies

#39

20110059486

2011-03-10

NON-SPLICING VARIANTS OF GP350/220

#40

20110033494

2011-02-10

Anti-infective agents and uses thereof

#41

20110002983

2011-01-06

Normuramyl glycopeptide compounds

#42

20100285051

2010-11-11

VACCINE

#43

20100203136

2010-08-12

METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (Hcg) VACCINE FOR LONG-ACTING ANTIBODY PROTECTION

#44

20100183708

2010-07-22

Antigen delivery vectors and constructs

#45

20100183650

2010-07-22

Antigen delivery vectors and constructs

#46

20090263412

2009-10-22

Non-Splicing Variants of gp350/220

#47

20090258033

2009-10-15

HCV E1E2 vaccine compositions

#48

20090092666

2009-04-09

Vaccines with enhanced immune response and methods for their preparation

#49

20090074853

2009-03-19

Vaccines with enhanced immune response and methods for their preparation

#50

20080008724

2008-01-10

Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails

#51

20070292386

2007-12-20

Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents

#52

20070275006

2007-11-29

IRIDOID GLYCOSIDE COMPOSITION

#53

20070202122

2007-08-30

Non-splicing variants of gp350/220

#54

20070154917

2007-07-05

Adjuvant comprising non-toxic cross-linked muramyl dipeptide (MDP) microparticles derived from Propionibacterium acnes

#55

20070041986

2007-02-22

Synthetic polysaccharide antigens for immunological intervention in disease

#56

20060246088

2006-11-02

Use of HIV-1 gp120 and gp160 proteins modified in the V3 loop for the preparation of vaccine compositions and formulations containing the same

#57

20060171917

2006-08-03

Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents

#58

20060134141

2006-06-22

Glycoconjugate vaccines containing peptidoglycan

#59

20060062741

2006-03-23

Intranasal immunization with detoxified lipooligosaccharide from nontypeable or

#60

20060018900

2006-01-26

Self antigen vaccines for treating B-cell lymphomas and other cancers

#61

20060013820

2006-01-19

Antigen delivery vectors and constructs

#62

20050255124

2005-11-17

HCV E1E2 vaccine compositions

#63

20050079186

2005-04-14

Therapeutic vaccine peptide complex for preventing and treating disorders in mammals

#64

20050043529

2005-02-24

Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant

#65

20050019339

2005-01-27

Vaccines with enhanced immune response and methods for their preparation